These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10954004)

  • 1. Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipients.
    Rump LC; Oberhauser V; Schwertfeger E; Speidel L; Zimmerhackl L; Kirste G; Grotz W
    J Hypertens; 2000 Aug; 18(8):1115-9. PubMed ID: 10954004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
    Kuypers DR; Neumayer HH; Fritsche L; Budde K; Rodicio JL; Vanrenterghem Y;
    Transplantation; 2004 Oct; 78(8):1204-11. PubMed ID: 15502721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal functional reserve in calcium channel blocker-treated hypertensive recipients of kidney transplant.
    Tack I; Rostaing L; Tran-Van T; Lloveras JJ; Durand D; Suc JM; Ader JL
    Nephrol Dial Transplant; 1995; 10 Suppl 6():117-9. PubMed ID: 8524480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial.
    Rahn KH; Barenbrock M; Fritschka E; Heinecke A; Lippert J; Schroeder K; Hauser I; Wagner K; Neumayer HH
    Lancet; 1999 Oct; 354(9188):1415-20. PubMed ID: 10543667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function.
    Barenbrock M; Colmorgen U; Firschka E; Gellert J; Lippert J; Schröder K; Spieker C; Voigt-Ladner G; Wagner K; Neumayer HH
    Clin Nephrol; 1995 Jun; 43(6):388-91. PubMed ID: 7554523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients.
    Sennesael JJ; Lamote JG; Violet I; Tasse S; Verbeelen DL
    Am J Kidney Dis; 1996 May; 27(5):701-8. PubMed ID: 8629631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M; Ganzel B
    J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study.
    Midtvedt K; Ihlen H; Hartmann A; Bryde P; Bjerkely BL; Foss A; Fauchald P; Holdaas H
    Transplantation; 2001 Jul; 72(1):107-11. PubMed ID: 11468543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients.
    Venkat-Raman G; Feehally J; Elliott HL; Griffin P; Moore RJ; Olubodun JO; Wilkinson R
    Nephrol Dial Transplant; 1998 Oct; 13(10):2612-6. PubMed ID: 9794569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.
    Midtvedt K; Hartmann A; Foss A; Fauchald P; Nordal KP; Rootwelt K; Holdaas H
    Transplantation; 2001 Dec; 72(11):1787-92. PubMed ID: 11740389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK; Sørensen SS; Hansen HE; Pedersen EB
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants.
    Mourad G; Ribstein J; Mimran A
    Kidney Int; 1993 Feb; 43(2):419-25. PubMed ID: 8382753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?
    Aybal Kutlugun A; Altun B; Buyukasik Y; Aki T; Turkmen E; Altindal M; Yildirim T; Yilmaz R; Turgan C
    Transpl Int; 2012 Jan; 25(1):13-8. PubMed ID: 21923802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proteinuric effect of an N-type calcium channel blocker, cilnidipine.
    Tsuchihashi T; Ueno M; Tominaga M; Kajioka T; Onaka U; Eto K; Goto K
    Clin Exp Hypertens; 2005 Nov; 27(8):583-91. PubMed ID: 16303635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.